Market Research Hub

Macular Degeneration Treatment Market: Application of Anti-VEGFs to Treat Wet AMD Soars

Age-related macular degeneration is one of the main causes of irreversible, severe vision impairment in developed countries.


Albany, NY -- (SBWIRE) -- 04/26/2019 -- The incidence, prevalence and progression of age-related macular degeneration surge with age. Given age-related macular degeneration leads vision to be distorted, colors to fade and impaired adaption to dark, thereby reducing quality of life; significance of macular degeneration treatment has soared. These actionable insights are according to the report titled, "Macular Degeneration Treatment Market—Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026," which has been freshly added to Market Research Hub's (MRH) ever-expanding repository.

Get Sample Copy of this Report@

On the basis of aging population demographics in the U.S., people affected by advanced AMD in at least one eye are projected to increase to nearly 3 million by 2020, states American Academy of Ophthalmology. This projection will be affected by efficacious treatments for the neovascular forms of AMD using anti-vascular endothelial growth factor (VEGF) agents and derailing the progression of disease using antioxidant vitamins with zinc. Besides, exudative AMD, also called as wet AMD, is now treated with drugs which impede VEGF agents. At the time when pertinent players are launching anti-VEGFs, Novartis' longer-acting anti-VEGF, brolucizumab is anticipated to propel the wet AMD segment during the assessment period. Though there is no proven therapy to prevent or treat geographic atrophy, manufacturers are launching novel products for the treatment of late stage of dry AMD and wet AMD.

Request Report TOC @

Macular Degeneration Treatment Market: Report Content

This report offers a thorough analysis on macular degeneration treatment market underpinned by quantitative and qualitative assessment. Further, the report shows the dynamics of the market, encompassing drivers, trends, opportunities, and restraints which have considerable impact in the development of macular degeneration treatment market. The report also incorporates segmentation of the market to provide a comprehensive analysis of the macular degeneration treatment. The report incorporates executive summary and market overview section. The macular degeneration treatment market overview section elucidates key trend analysis, value chain analysis and Porters' Five Force Analysis. Essentially, Porters' Five Force Analysis provides actionable insights on competitive scenario of the market. Furthermore, the report also encompasses the market attractiveness analysis as well as market outlook. The report delves into macroeconomic factors such as profitability of enterprises and economic outlook. Moreover, the macroeconomic factors also provides an in-depth assessment on inflation and deflation. The report also peruses into the complex eco-system and risk mitigation to further elucidate the macular degeneration treatment market. A thorough analysis of competitive scenario of the macular degeneration treatment market is backed up by a thorough assessment of Porters' Five Force Analysis. The report deals with financial overview, company overview, strategies, recent development, sales footprint and product portfolio.

Macular Degeneration Treatment Market: Research Methodology

The assessment in the report is backed up by primary sources, incorporating an unbiased and veracious views of seasoned analyst, surveys, interviews, interactions in person and assessment by experts. Additionally, the report is bolstered by secondary sources encompassing verified paid source, trade journals and resourceful database. The report is also propelled by absolute dollar opportunity analysis which significant impact in furthering the development of the macular degeneration treatment market.